Upperton establishes spray drying partnership with Quotient Clinical
Nottingham, UK – 28th May, 2016 — Upperton has entered into a partnership with Quotient Clinical, the Translational Pharmaceutics® Company, to deliver a complete spray drying service for pharmaceutical and biotechnology companies seeking to develop spray dried formulations for clinical use. The partnership will see Upperton working with Quotient Clinical to supply GMP manufacturing services at Quotient within the MediCity life science innovation hub in Nottingham, UK.
Richard Johnson, CEO and Founder of Upperton commented “We are really pleased to announce this partnership with Quotient, which allows us to streamline the transfer of formulation development projects into pilot GMP manufacturing to support our customers’ preclinical and clinical development programs. Our first joint program has been delivered successfully and has validated the time savings that can be delivered for our customers as a result of our co-location and close working relationship with Quotient”
“Spray drying is now emerging as one of the fastest-growing formulation technologies with broad utility across a wide range of applications in the pharmaceutical and biotechnology industry. This partnership will allow Upperton to provide our customers with a seamless transition from initial feasibility and development studies right through to cGMP spray drying and production of the final dosage form for human clinical trials.” added Dr Johnson
Mark Egerton, CEO of Quotient Clinical said “Spray drying is a key technology used to address the industry problem of poor solubility and bioavailability and is an established capability within our service portfolio. Upperton have more than 20 years spray drying experience and this partnership both reinforces our existing experience in small molecules, whilst extending our capabilities into biologics which is a new and exciting opportunity for us”.
Quotient Clinical has brought innovation to the drug development process through its unique Translational Pharmaceutics platform, which challenges conventional development approaches by integrating formulation development, real time GMP manufacturing, and clinical testing. The approach is proven to accelerate project timelines and reduce costs.
If you would like to discuss a project you have in the pipeline or learn more about our spray drying service, contact us using the address below.
Dr Richard Johnson, Founding Director
Telephone (U.K.) +44 (0) 115 784 0077.